论文部分内容阅读
美国研究者最近报道 ,在未来几年里 ,生殖器疱疹疫苗将有可能用于临床。两项临床试验结果表明 ,一种含糖蛋白 D亚单位的疫苗能够使 70 %以上单纯性疱疹 1和 2 (HSV Ⅰ /Ⅱ )血清阴性的妇女得到预防 ,但对男性无效。2 714名受试者 (其中女性 978名 )都具生殖器疱疹传染史的固定
US researchers recently reported that genital herpes vaccines will likely be used clinically in the coming years. Two clinical trials show that a vaccine containing the glycoprotein D subunit can prevent over 70% of women with seronegative herpes simplex 1 and 2 (HSV Ⅰ / Ⅱ) but not in men. 2 714 subjects (978 of them women) had a history of genital herpes infection